Inflammation-based lung adenocarcinoma molecular subtype identification and construction of an inflammation-related signature with bulk and single-cell RNA-seq data

The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However, the detailed molecular divisions involved in inflammatory responses are yet to be fully elucidated. Our study identified two main inflammation...

Full description

Saved in:
Bibliographic Details
Published inAging (Albany, NY.) Vol. 16; no. 10; pp. 8822 - 8842
Main Authors Gu, Yan, Bian, Chengyu, Wang, Hongchang, Fu, Chenghao, Xue, Wentao, Zhang, Wenhao, Mu, Guang, Xia, Yang, Wei, Ke, Wang, Jun
Format Journal Article
LanguageEnglish
Published United States Impact Journals 20.05.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However, the detailed molecular divisions involved in inflammatory responses are yet to be fully elucidated. Our study identified two main inflammation-oriented LUAD grades: the inflammation-low (INF-low) and the inflammation-high (INF-high) subtypes. Both presented with unique clinicopathological features, implications for prognosis, and distinctive tumor microenvironment profiles. Broadly, the INF-low grade, marked by its dominant immunosuppressive tumor microenvironment, was accompanied by less favorable prognostic outcomes and a heightened prevalence of oncogenic mutations. In contrast, the INF-high grade exhibited more optimistic clinical trajectories, underscored by its immune-active environment. In addition, our efforts led to the conceptualization and empirical validation of an inflammation-centric predictive model with considerable predictive potency. Our study paves the way for a refined inflammation-centric LUAD classification and fosters a deeper understanding of tumor microenvironment intricacies.
AbstractList The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However, the detailed molecular divisions involved in inflammatory responses are yet to be fully elucidated. Our study identified two main inflammation-oriented LUAD grades: the inflammation-low (INF-low) and the inflammation-high (INF-high) subtypes. Both presented with unique clinicopathological features, implications for prognosis, and distinctive tumor microenvironment profiles. Broadly, the INF-low grade, marked by its dominant immunosuppressive tumor microenvironment, was accompanied by less favorable prognostic outcomes and a heightened prevalence of oncogenic mutations. In contrast, the INF-high grade exhibited more optimistic clinical trajectories, underscored by its immune-active environment. In addition, our efforts led to the conceptualization and empirical validation of an inflammation-centric predictive model with considerable predictive potency. Our study paves the way for a refined inflammation-centric LUAD classification and fosters a deeper understanding of tumor microenvironment intricacies.
The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However, the detailed molecular divisions involved in inflammatory responses are yet to be fully elucidated. Our study identified two main inflammation-oriented LUAD grades: the inflammation-low (INF-low) and the inflammation-high (INF-high) subtypes. Both presented with unique clinicopathological features, implications for prognosis, and distinctive tumor microenvironment profiles. Broadly, the INF-low grade, marked by its dominant immunosuppressive tumor microenvironment, was accompanied by less favorable prognostic outcomes and a heightened prevalence of oncogenic mutations. In contrast, the INF-high grade exhibited more optimistic clinical trajectories, underscored by its immune-active environment. In addition, our efforts led to the conceptualization and empirical validation of an inflammation-centric predictive model with considerable predictive potency. Our study paves the way for a refined inflammation-centric LUAD classification and fosters a deeper understanding of tumor microenvironment intricacies.The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However, the detailed molecular divisions involved in inflammatory responses are yet to be fully elucidated. Our study identified two main inflammation-oriented LUAD grades: the inflammation-low (INF-low) and the inflammation-high (INF-high) subtypes. Both presented with unique clinicopathological features, implications for prognosis, and distinctive tumor microenvironment profiles. Broadly, the INF-low grade, marked by its dominant immunosuppressive tumor microenvironment, was accompanied by less favorable prognostic outcomes and a heightened prevalence of oncogenic mutations. In contrast, the INF-high grade exhibited more optimistic clinical trajectories, underscored by its immune-active environment. In addition, our efforts led to the conceptualization and empirical validation of an inflammation-centric predictive model with considerable predictive potency. Our study paves the way for a refined inflammation-centric LUAD classification and fosters a deeper understanding of tumor microenvironment intricacies.
Author Bian, Chengyu
Fu, Chenghao
Xia, Yang
Zhang, Wenhao
Gu, Yan
Wei, Ke
Mu, Guang
Wang, Jun
Wang, Hongchang
Xue, Wentao
Author_xml – sequence: 1
  givenname: Yan
  surname: Gu
  fullname: Gu, Yan
  organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China
– sequence: 2
  givenname: Chengyu
  surname: Bian
  fullname: Bian, Chengyu
  organization: Department of Thoracic Surgery, The First People’s Hospital of Changzhou and The Third Affiliated Hospital of Soochow University, Changzhou 213004, Jiangsu, China
– sequence: 3
  givenname: Hongchang
  surname: Wang
  fullname: Wang, Hongchang
  organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China
– sequence: 4
  givenname: Chenghao
  surname: Fu
  fullname: Fu, Chenghao
  organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China
– sequence: 5
  givenname: Wentao
  surname: Xue
  fullname: Xue, Wentao
  organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China
– sequence: 6
  givenname: Wenhao
  surname: Zhang
  fullname: Zhang, Wenhao
  organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China
– sequence: 7
  givenname: Guang
  surname: Mu
  fullname: Mu, Guang
  organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China
– sequence: 8
  givenname: Yang
  surname: Xia
  fullname: Xia, Yang
  organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China
– sequence: 9
  givenname: Ke
  surname: Wei
  fullname: Wei, Ke
  organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China
– sequence: 10
  givenname: Jun
  surname: Wang
  fullname: Wang, Jun
  organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38771142$$D View this record in MEDLINE/PubMed
BookMark eNpVkUlvFTEQhC0URJIHR67IRy4T7LE9ywlFEUukCCQEZ6vHy8TgsV-8gPJ_-KEM80L0ONnq_rpKpTpHJyEGg9BLSi7o0LH2DcwuzBctEQMnT9AZHblouBjGk6P_KTrP-TshnRC8e4ZO2dD3lPL2DP2-DtbDskBxMTQTZKOxr2HGoE2ICpJyIS6Al-iNqh4SznUq93uD3QoUZ53aTjEEjVUMuaSqtkG06wy7Y_lkPJTVILs5QKnJ4F-u3OKp-h_bfV6TeNMo4z3-8umyyeYOayjwHD214LN58fDu0Lf3775efWxuPn-4vrq8aRTjvDRq4FqbNRgIaJkRrCe8J4z3HbGDJYS1SjE9WtuOHVHtNHW9HRSdqNBaKd2xHXp70N3XaTFarQETeLlPboF0LyM4-f8muFs5x5-SUtpxsTrs0OsHhRTvqslFLi7_zQPBxJolI6LvRib6cUVfHZs9uvzrZgWaA6BSzDkZ-4hQIrfu5da9PHTP_gCzKaem
Cites_doi 10.1158/0008-5472.CAN-20-1994
10.1016/S0140-6736(16)30958-8
10.1158/0008-5472.CAN-18-0689
10.1038/nature25501
10.1016/j.celrep.2016.12.019
10.1038/s41467-020-16164-1
10.1093/nar/gkaa1020
10.1016/j.cell.2014.12.033
10.1038/nature07205
10.1016/j.tcb.2018.02.004
10.1038/s41467-021-26770-2
10.1183/13993003.00359-2016
10.1158/2326-6066.CIR-18-0822
10.3322/caac.21763
10.1038/s41591-018-0136-1
10.3390/cancers13030384
10.1038/s41423-020-0488-6
10.3322/caac.21660
10.1016/S1470-2045(14)70263-3
10.1038/ni.2060
10.1038/s41423-021-00756-y
10.3390/ijms22115421
10.1002/jcsm.13032
10.1002/phar.2663
10.1038/nature20123
10.1146/annurev-cellbio-100913-013325
10.1007/978-1-4939-7493-1_12
10.1038/s41392-021-00824-9
10.1093/bib/bbaa164
10.1038/nri.2017.142
10.1002/cac2.12025
10.1136/jitc-2021-003534
ContentType Journal Article
Copyright Copyright: © 2024 Gu et al.
Copyright_xml – notice: Copyright: © 2024 Gu et al.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.18632/aging.205840
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1945-4589
EndPage 8842
ExternalDocumentID PMC11164500
38771142
10_18632_aging_205840
Genre Journal Article
GroupedDBID ---
53G
AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
FRP
GX1
HYE
KQ8
M48
O5R
O5S
OK1
PGMZT
RPM
W2D
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c344t-c84dde711a5a23e537047034760f8f0032cc3d9ff2960c2bb67f8c1b15ddccd63
IEDL.DBID M48
ISSN 1945-4589
IngestDate Thu Aug 21 18:33:45 EDT 2025
Fri Jul 11 05:51:52 EDT 2025
Thu Apr 03 07:00:58 EDT 2025
Tue Jul 01 00:42:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 10
Keywords molecular subtypes
immune
tumor microenvironment
inflammation
lung adenocarcinoma
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c344t-c84dde711a5a23e537047034760f8f0032cc3d9ff2960c2bb67f8c1b15ddccd63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Equal contribution
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.18632/aging.205840
PMID 38771142
PQID 3057693579
PQPubID 23479
PageCount 21
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11164500
proquest_miscellaneous_3057693579
pubmed_primary_38771142
crossref_primary_10_18632_aging_205840
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20240520
PublicationDateYYYYMMDD 2024-05-20
PublicationDate_xml – month: 5
  year: 2024
  text: 20240520
  day: 20
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Aging (Albany, NY.)
PublicationTitleAlternate Aging (Albany NY)
PublicationYear 2024
Publisher Impact Journals
Publisher_xml – name: Impact Journals
References Cuculich (11) 2022; 4
Karin (29) 2011; 1
Jülicher (31) 2014; 3
Balkwill (14) 2008; 45
Alizadeh (19) 2018; 171
Zhang (24) 2021; 4
Bray (1) 2021; 7
Stathopoulos (15) 2021; 1
Paz-Ares (7) 2017; 38
Zhang (16) 2020; 1
Karin (30) 2018; 1
Yarchoan (20) 2019; 7
Di (9) 2021; 8
Yang (10) 2022; 1
Li (22) 2018; 7
Taniguchi (13) 2021; 2
Guo (4) 2021; 1
Trajanoski (21) 2017; 1
Boffetta (8) 2016; 4
Joung (17) 2020; 1
Li (5) 2022; 7
Zhou (6) 2022; 1
Clarke (25) 2014; 1
Jemal (2) 2023; 7
Nyman (23) 2016; 53
Hacohen (27) 2015; 16
Brown (26) 2018; 2
Dai (28) 2021; 2
Shalapour (12) 2022; 1
Yang (18) 2018; 55
Fuxreiter (32) 2018; 2
Chen (3) 2020; 4
References_xml – volume: 8
  start-page: 144
  year: 2021
  ident: 9
  article-title: Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen-Induced Lung Cancer and Determines the Efficacy of Immunotherapy.
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-20-1994
– volume: 38
  start-page: 299
  year: 2017
  ident: 7
  article-title: Lung cancer: current therapies and new targeted treatments.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)30958-8
– volume: 7
  start-page: 6575
  year: 2018
  ident: 22
  article-title: TIP: A Web Server for Resolving Tumor Immunophenotype Profiling.
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-0689
– volume: 55
  start-page: 544
  year: 2018
  ident: 18
  article-title: TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
  publication-title: Nature
  doi: 10.1038/nature25501
– volume: 1
  start-page: 248
  year: 2017
  ident: 21
  article-title: Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2016.12.019
– volume: 1
  start-page: 2285
  year: 2020
  ident: 17
  article-title: Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma.
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-16164-1
– volume: 4
  start-page: D1420
  year: 2021
  ident: 24
  article-title: TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment.
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkaa1020
– volume: 16
  start-page: 48
  year: 2015
  ident: 27
  article-title: Molecular and genetic properties of tumors associated with local immune cytolytic activity.
  publication-title: Cell
  doi: 10.1016/j.cell.2014.12.033
– volume: 45
  start-page: 436
  year: 2008
  ident: 14
  article-title: Cancer-related inflammation.
  publication-title: Nature
  doi: 10.1038/nature07205
– volume: 2
  start-page: 420
  year: 2018
  ident: 32
  article-title: Protein Phase Separation: A New Phase in Cell Biology.
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2018.02.004
– volume: 1
  start-page: 6500
  year: 2021
  ident: 4
  article-title: Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing.
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-26770-2
– volume: 4
  start-page: 889
  year: 2016
  ident: 8
  article-title: Risk factors for lung cancer worldwide.
  publication-title: Eur Respir J
  doi: 10.1183/13993003.00359-2016
– volume: 7
  start-page: 886
  year: 2019
  ident: 20
  article-title: Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival.
  publication-title: Cancer Immunol Res
  doi: 10.1158/2326-6066.CIR-18-0822
– volume: 7
  start-page: 17
  year: 2023
  ident: 2
  article-title: Cancer statistics, 2023.
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21763
– volume: 2
  start-page: 1550
  year: 2018
  ident: 26
  article-title: Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0136-1
– volume: 1
  start-page: 384
  year: 2021
  ident: 15
  article-title: Immune Resistance in Lung Adenocarcinoma.
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers13030384
– volume: 1
  start-page: 807
  year: 2020
  ident: 16
  article-title: The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-020-0488-6
– volume: 7
  start-page: 209
  year: 2021
  ident: 1
  article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 1
  start-page: e493
  year: 2014
  ident: 25
  article-title: Cancer-related inflammation and treatment effectiveness.
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(14)70263-3
– volume: 1
  start-page: 715
  year: 2011
  ident: 29
  article-title: Inflammation meets cancer, with NF-κB as the matchmaker.
  publication-title: Nat Immunol
  doi: 10.1038/ni.2060
– volume: 1
  start-page: 59
  year: 2022
  ident: 12
  article-title: Regulation of antitumor immunity by inflammation-induced epigenetic alterations.
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-021-00756-y
– volume: 2
  start-page: 5421
  year: 2021
  ident: 13
  article-title: Inflammation-Induced Tumorigenesis and Metastasis.
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22115421
– volume: 1
  start-page: 2504
  year: 2022
  ident: 10
  article-title: The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer.
  publication-title: J Cachexia Sarcopenia Muscle
  doi: 10.1002/jcsm.13032
– volume: 4
  start-page: 250
  year: 2022
  ident: 11
  article-title: The role of inflammation in the pathogenesis and treatment of arrhythmias.
  publication-title: Pharmacotherapy
  doi: 10.1002/phar.2663
– volume: 53
  start-page: 309
  year: 2016
  ident: 23
  article-title: Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma.
  publication-title: Nature
  doi: 10.1038/nature20123
– volume: 3
  start-page: 39
  year: 2014
  ident: 31
  article-title: Liquid-liquid phase separation in biology.
  publication-title: Annu Rev Cell Dev Biol
  doi: 10.1146/annurev-cellbio-100913-013325
– volume: 171
  start-page: 243
  year: 2018
  ident: 19
  article-title: Profiling Tumor Infiltrating Immune Cells with CIBERSORT.
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-4939-7493-1_12
– volume: 7
  start-page: 9
  year: 2022
  ident: 5
  article-title: Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer.
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00824-9
– volume: 2
  start-page: bbaa164
  year: 2021
  ident: 28
  article-title: Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology.
  publication-title: Brief Bioinform
  doi: 10.1093/bib/bbaa164
– volume: 1
  start-page: 309
  year: 2018
  ident: 30
  article-title: NF-κB, inflammation, immunity and cancer: coming of age.
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri.2017.142
– volume: 4
  start-page: 205
  year: 2020
  ident: 3
  article-title: Cancer burden of major cancers in China: A need for sustainable actions.
  publication-title: Cancer Commun (Lond)
  doi: 10.1002/cac2.12025
– volume: 1
  start-page: e003534
  year: 2022
  ident: 6
  article-title: Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2021-003534
SSID ssj0065546
Score 2.3730178
Snippet The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However,...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 8822
SubjectTerms Adenocarcinoma of Lung - genetics
Adenocarcinoma of Lung - immunology
Adenocarcinoma of Lung - pathology
Aged
Female
Gene Expression Regulation, Neoplastic
Humans
Inflammation - genetics
Lung Neoplasms - genetics
Lung Neoplasms - immunology
Lung Neoplasms - pathology
Male
Middle Aged
Prognosis
Research Paper
RNA-Seq
Single-Cell Analysis
Single-Cell Gene Expression Analysis
Tumor Microenvironment - genetics
Tumor Microenvironment - immunology
Title Inflammation-based lung adenocarcinoma molecular subtype identification and construction of an inflammation-related signature with bulk and single-cell RNA-seq data
URI https://www.ncbi.nlm.nih.gov/pubmed/38771142
https://www.proquest.com/docview/3057693579
https://pubmed.ncbi.nlm.nih.gov/PMC11164500
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB61IBAXVKCPpS0yUtVbqONn9oAqVBUoEhyqrrS3yHZisepuUlhWKv-nP5SZJLuw0BOXHBKPo_jLvOx5AHwylGGtQ0xSiRflOE889TeJzsTM9gOZHBRtcWFOB-psqIf3JYW6BZz-17WjflKD6_HB36vbr8jwh8TwmZHiS9PPB309VKbova-iUrLEo-dqcaBgKBirK7H5hGQD1mVmLWWVLmunJybn48jJB6ro-BVsdjYkO2pB34IXZbUNa21XydttWD_vzst34N-PKiLkbXpiQhqrYGNkb-ZQ3KAWu8Zh9cSxybxJLpvOPO3KslHRhRE1pMxVBQv1fbVZVke8x0YPp2_SYvAFFBLSlAtltMnL_Gz8u6GnXYlxmdBRAft5cZRMyytGAaqvYXD8_de306Try5AEqdRNEjKFQhHXy2knZKml5QoFh7KGxyyimBAhyKIfo0D3KAjvjY1ZSH2qiyKEwsg3sFLVVfkOWOq1RZuDB-el8kJnXPRTVwrlZRFscD34PMcj_9OW38jJbSEM8wbDvMWwB_tztHJkEPoUV5X1bJqjQKN-j9r2e_C2RW8x1Rz2HmRLuC4GUPHt5SfV6LIpwo06wijN-e7zSd_DhkATiWIRBP8AKwhh-RFNnBu_By9Phule8wvfASbpAsk
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inflammation-based+lung+adenocarcinoma+molecular+subtype+identification+and+construction+of+an+inflammation-related+signature+with+bulk+and+single-cell+RNA-seq+data&rft.jtitle=Aging+%28Albany%2C+NY.%29&rft.au=Gu%2C+Yan&rft.au=Bian%2C+Chengyu&rft.au=Wang%2C+Hongchang&rft.au=Fu%2C+Chenghao&rft.date=2024-05-20&rft.pub=Impact+Journals&rft.eissn=1945-4589&rft.volume=16&rft.issue=10&rft.spage=8822&rft.epage=8842&rft_id=info:doi/10.18632%2Faging.205840&rft_id=info%3Apmid%2F38771142&rft.externalDocID=PMC11164500
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1945-4589&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1945-4589&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1945-4589&client=summon